GlassScriptPhysician profile
David M Choi
NPI 1912981598
$4,024.42
in general payments reported to CMS, 2019-2025
32 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what 80% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $335 · 2021: $434 · 2022: $288 · 2023: $617 · 2024: $640 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,632.70 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $885.75 | 2024-2025 | Acthar |
| Glaukos Corporation | $447.22 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $420.58 | 2019-2025 | Catalys System, Tecnis Simplicity, Tecnis Iol |
| Alcon Vision LLC | $419.76 | 2019-2024 | Clareon, Acrysof Iq Vivity, Hydrus Microstent |
| Amgen INC. | $357.14 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $235.11 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $158.45 | 2020-2021 | |
| Sight Sciences, INC. | $149.00 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Boston Scientific Corporation | $125.00 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $117.34 | 2025 | Rexulti |
| Tarsus Pharmaceuticals, INC. | $74.09 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $62.16 | 2024-2025 | Oxervate |
| Abbvie INC. | $58.93 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $52.32 | 2024-2025 | Xiidra, Miebo |
| Thea Pharma INC. | $43.47 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $41.06 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $35.62 | 2023 | Interstim |
| Optos, INC. | $35.04 | 2019 | |
| Shire North American Group INC | $32.71 | 2019 | |
| Janssen Biotech, INC. | $31.11 | 2024 | Erleada, Akeega, Balversa |
| Irhythm Technologies, INC. | $27.32 | 2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.56 | 2024 | Lifevest |
| Viiv Healthcare Company | $22.96 | 2024 | Cabenuva |
| Rxsight INC | $22.62 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Nevro Corp. | $21.79 | 2019 | |
| Myriad Women'S Health, INC. | $21.18 | 2023 | Myrisk |
| Nestle Healthcare Nutrition INC. | $18.88 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $18.29 | 2023 | Lumera, Lumera 700, Quatera 700 |
| Merck Sharp & Dohme LLC | $18.05 | 2022 | |
| Kala Pharmaceuticals, INC. | $17.67 | 2022 | |
| Sumitomo Pharma America, INC. | $16.72 | 2023 | Orgovyx |
| Karyopharm Therapeutics INC. | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.